SynsoryBio
"If-then" conditional logic for protein drugs
Cambridge, United States · Founded 2023
- Headquarters
- Cambridge, Massachusetts
- Employees
- 1–10
- Founded
- 2023
- Website
- synsorybio.com
- Last Round
- GrantApr 2024
- Rounds
- 2
About
SynsoryBio is creating next generation, protein therapeutics that sense where they are in the body and only activate at diseased tissue. This technology platform has the potential to expand the therapeutic window of highly potent drugs and apply to many diseases such as cancer and autoimmune disorders.
Summary
SynsoryBio is a Biotech company based in Cambridge, United States, founded in 2023. Its most recent funding was a Grant round in Apr 2024.
Funding History
Apr 2024
Sign up to see all 2 rounds
Grant through Seed — per-round amounts, valuations, and who invested in each round.
Similar Companies
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Specialty pharmaceutical company focused on addressing therapeutic needs in the fields of psychia...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/synsorybio"><img src="https://indexed.vc/api/badge/company/synsorybio" alt="SynsoryBio on Indexed.vc" width="260" height="76" /></a>